COMMUNIQUÉS West-GlobeNewswire

-
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
03/04/2024 - 22:05 -
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/04/2024 - 22:05 -
Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
03/04/2024 - 22:05 -
Nkarta to Participate in Upcoming Investor Conferences
03/04/2024 - 22:02 -
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
03/04/2024 - 22:01 -
Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F
03/04/2024 - 22:00 -
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son Rapport Annuel 2023 (« Form 20-F »)
03/04/2024 - 22:00 -
Two Legend Senior Living® Directors Receive Prestigious Hero Awards From the Texas Assisted Living Association (TALA)
03/04/2024 - 22:00 -
Merus participera à une discussion informelle lors de la 23e conférence annuelle Needham Virtual Healthcare
03/04/2024 - 20:23 -
UPDATE – Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend
03/04/2024 - 20:02 -
NH Nonprofit Heralds New Research Documenting Community Healthcare Workers
03/04/2024 - 20:00 -
IBEX Shareholders Approve Sale of the Company
03/04/2024 - 18:36 -
CARBIOS annonce le vif succès de son premier plan d'actionnariat salarié
03/04/2024 - 18:30 -
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
03/04/2024 - 18:09 -
AB Science annonce que Santé Canada a jugé admissible la demande de réexamen du masitinib dans SLA
03/04/2024 - 18:09 -
Transparency Notifications from Shareholders
03/04/2024 - 18:00 -
Informations relatives au nombre total de droits de vote et d’actions composant le capital
03/04/2024 - 18:00 -
Le KFSH&RC accueille le Dr Björn Zoëga en tant que nouveau directeur général adjoint
03/04/2024 - 17:37 -
ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM
03/04/2024 - 17:30
Pages